|
86 Companies |
|
137 Products |
|
137 Products |
|
85 Mechanisms of Action |
|
4 Trials |
|
2019 News |
|
| «12...28293031323334353637383940» |
- Clinical: Clinical Symptoms of Schizophrenia and Physical Exercise (clinicaltrials.gov) - Aug 27, 2012
P=N/A, N=41, Recruiting, Sponsor: Federal University of São Paulo
- furosemide / Generic mfg.
Trial completion: MRS: The Effect of Plasma Osmolality on Brain Glutamate (clinicaltrials.gov) - Aug 22, 2012
P1/2, N=30, Completed, Sponsor: Yale University
Recruiting --> Completed
- ||||||| paliperidone extended release / Generic mfg.
Trial completion: Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. (clinicaltrials.gov) - Aug 22, 2012
P3, N=400, Completed, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness (clinicaltrials.gov) - Aug 21, 2012
P=N/A, N=55, Active, not recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed N=35 --> 55
- haloperidol / Generic mfg., quetiapine / Generic mfg.
Trial completion: Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia (clinicaltrials.gov) - Aug 20, 2012
P=N/A, N=80, Completed, Sponsor: Peking University
N=35 --> 55 Active, not recruiting --> Completed
- | risperidone / Generic mfg., paliperidone extended release / Generic mfg.
New P4 trial: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia (clinicaltrials.gov) - Aug 19, 2012
P4, N=50, Recruiting, Sponsor: Johnson & Johnson Taiwan Ltd
- |||||||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
New P3 trial: EQUATOR: Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia (clinicaltrials.gov) - Aug 16, 2012
P3, N=420, Recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- Trial completion: Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia (clinicaltrials.gov) - Aug 14, 2012
P4, N=57, Completed, Sponsor: University of Massachusetts, Worcester
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: MSG: Effectiveness of Family Group Interventions for People With Schizophrenia (clinicaltrials.gov) - Aug 14, 2012
P2, N=128, Completed, Sponsor: The Hong Kong Polytechnic University
Recruiting --> Completed Recruiting --> Completed
- Wakix (pitolisant) / Ferrer International, Paragon Biosci, Aculys Pharma
Trial completion: Study to Demonstrate Cognitive Enhancing Effects of BF2.649 (clinicaltrials.gov) - Aug 14, 2012
P2, N=52, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Effect of Single Dose Intranasal Insulin On Cognitive Function (clinicaltrials.gov) - Aug 14, 2012
P4, N=30, Completed, Sponsor: University of Massachusetts, Worcester
Recruiting --> Completed Active, not recruiting --> Completed
- aripiprazole / Generic mfg., clozapine / Generic mfg.
Enrollment change, Adverse events: Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia (clinicaltrials.gov) - Aug 13, 2012
P4, N=38, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed N=70 --> 38
- aripiprazole / Generic mfg., clozapine / Generic mfg.
Trial completion, Adverse events: Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia (clinicaltrials.gov) - Aug 13, 2012
P4, N=38, Completed, Sponsor: Massachusetts General Hospital
N=70 --> 38 Active, not recruiting --> Completed
- Trial completion: GEBRCT: Improving Insight in Patients Diagnosed With Schizophrenia (clinicaltrials.gov) - Aug 12, 2012
P=N/A, N=101, Completed, Sponsor: University of Aarhus
Active, not recruiting --> Completed Active, not recruiting --> Completed
- clozapine / Generic mfg.
New P4 trial: Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients (clinicaltrials.gov) - Aug 9, 2012
P4, N=20, Not yet recruiting, Sponsor: Tirat Carmel Mental Health Center
- |||||||||| Abilify Maintena (aripiprazole extended release) / Otsuka, Lundbeck
New P3 trial: Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia (clinicaltrials.gov) - Aug 9, 2012
P3, N=340, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- |||||||||| paliperidone extended release / Generic mfg.
New P3 trial: Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia (clinicaltrials.gov) - Aug 8, 2012
P3, N=1117, Completed, Sponsor: Janssen Pharmaceutica
- |||||||||| paliperidone extended release / Generic mfg.
New P3 trial: An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia (clinicaltrials.gov) - Aug 8, 2012
P3, N=202, Completed, Sponsor: Janssen Research & Development, LLC
- amisulpride / Generic mfg.
Trial initiation date: Optimisation of Antipsychotic Drug Use in Older People (clinicaltrials.gov) - Aug 7, 2012
P4, N=120, Recruiting, Sponsor: Institute of Psychiatry, London
Active, not recruiting --> Completed Initiation date: Nov 2011 --> May 2012
- amisulpride / Generic mfg.
Enrollment open: Optimisation of Antipsychotic Drug Use in Older People (clinicaltrials.gov) - Aug 7, 2012
P4, N=120, Recruiting, Sponsor: Institute of Psychiatry, London
Initiation date: Nov 2011 --> May 2012 Not yet recruiting --> Recruiting
- Enrollment change: Family Intervention for Mental Illness and Substance Abuse (clinicaltrials.gov) - Aug 6, 2012
P=N/A, N=108, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Not yet recruiting --> Recruiting N=140 --> 108
- Trial completion: Family Intervention for Mental Illness and Substance Abuse (clinicaltrials.gov) - Aug 6, 2012
P=N/A, N=108, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
N=140 --> 108 Active, not recruiting --> Completed
- Trial initiation date, Adherence: SPERA-S: Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=280, Not yet recruiting, Sponsor: University of Cagliari
Active, not recruiting --> Completed Initiation date: Nov 2011 --> Sep 2012
- Trial completion: Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses (clinicaltrials.gov) - Aug 1, 2012
P=N/A, N=200, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Initiation date: Nov 2011 --> Sep 2012 Recruiting --> Completed
- pregabalin / Generic mfg.
Enrollment open: PACS: Pregablin for Anxiety-comorbidity in Patients With Schizophrenia (clinicaltrials.gov) - Jul 31, 2012
P4, N=70, Recruiting, Sponsor: University of Aarhus
Recruiting --> Completed Not yet recruiting --> Recruiting
- | metformin / Generic mfg., clozapine / Generic mfg.
New P4 trial: The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine (clinicaltrials.gov) - Jul 30, 2012
P4, N=30, Recruiting, Sponsor: Seoul National University Hospital
- clozapine / Generic mfg.
New P1 trial: DWCZP-I-1: A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril (clinicaltrials.gov) - Jul 30, 2012
P1, N=28, Completed, Sponsor: Dong Wha Pharmaceutical Co. Ltd.
- Trial completion: Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=120, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting --> Recruiting Recruiting --> Completed
- | Targretin oral (bexarotene oral) / ReXceptor
Trial completion: Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia (clinicaltrials.gov) - Jul 24, 2012
P3, N=90, Completed, Sponsor: Beersheva Mental Health Center
Recruiting --> Completed Recruiting --> Completed
- ||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
New P2 trial, Monotherapy: STEP 210: Multicenter, Open-label, Safety and Tolerability Study (clinicaltrials.gov) - Jul 23, 2012
P2, N=244, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- Trial completion: Introduction Seminar About Patient Participation and Treatment Options for Psychiatric Patients on Waiting List (clinicaltrials.gov) - Jul 23, 2012
P=N/A, N=92, Completed, Sponsor: Norwegian University of Science and Technology
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women (clinicaltrials.gov) - Jul 19, 2012
P3, N=300, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial initiation date: Healthy Bodies, Healthy Kids (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=126, Recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Initiation date: Mar 2011 --> Jul 2011
- | Abilify Maintena (aripiprazole extended release) / Otsuka, Lundbeck
New P1 trial: An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia (clinicaltrials.gov) - Jul 18, 2012
P1, N=37, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- Enrollment open: Healthy Bodies, Healthy Kids (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=126, Recruiting, Sponsor: Washington University School of Medicine
Initiation date: Mar 2011 --> Jul 2011 Not yet recruiting --> Recruiting
- Trial completion, MRI: Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy Controls (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=21, Completed, Sponsor: University of Bristol
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Trial completion: Impact of Genetic Counseling for Individuals With Mental Illness (clinicaltrials.gov) - Jul 10, 2012
P3, N=120, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial initiation date: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=90, Completed, Sponsor: University of California, Los Angeles
Active, not recruiting --> Completed Initiation date: Jan 2007 --> Mar 2008
- carbidopa/levodopa / Generic mfg.
New P2 trial: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Jul 8, 2012
P2, N=24, Recruiting, Sponsor: Centre for Addiction and Mental Health
- Trial completion: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=90, Completed, Sponsor: University of California, Los Angeles
Initiation date: Jan 2007 --> Mar 2008 Active, not recruiting --> Completed
- | ziprasidone / Generic mfg.
Trial completion: 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study (clinicaltrials.gov) - Jul 5, 2012
P=N/A, N=12, Completed, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Completed Active, not recruiting --> Completed
- modafinil / Generic mfg.
Enrollment change: InO: Modafinil Effects on Cognition in Schizophrenia Patients (clinicaltrials.gov) - Jul 4, 2012
P4, N=40, Completed, Sponsor: University of California, Davis
Active, not recruiting --> Completed N=80 --> 40
- New P2 trial: Acute Effects of Exercise in Smokers With Schizophrenia (clinicaltrials.gov) - Jul 4, 2012
P2, N=32, Recruiting, Sponsor: Brown University
- quetiapine / Generic mfg.
New P1 trial: Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets (clinicaltrials.gov) - Jul 4, 2012
P1, N=0, Completed, Sponsor: Torrent Pharmaceuticals Limited
- modafinil / Generic mfg.
Trial completion: InO: Modafinil Effects on Cognition in Schizophrenia Patients (clinicaltrials.gov) - Jul 4, 2012
P4, N=40, Completed, Sponsor: University of California, Davis
N=80 --> 40 Recruiting --> Completed
- tetrabenazine / Generic mfg.
Enrollment change: Tetrabenazine for Partial Responders (clinicaltrials.gov) - Jul 3, 2012
P=N/A, N=41, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed N=60 --> 41
- tetrabenazine / Generic mfg.
Trial completion: Tetrabenazine for Partial Responders (clinicaltrials.gov) - Jul 3, 2012
P=N/A, N=41, Completed, Sponsor: Centre for Addiction and Mental Health
N=60 --> 41 Active, not recruiting --> Completed
- olanzapine / Generic mfg., amisulpride / Generic mfg., clozapine / Generic mfg.
Trial initiation date: OPTIMISE: Optimization of Treatment and Management of Schizophrenia in Europe (clinicaltrials.gov) - Jun 28, 2012
P4, N=350, Recruiting, Sponsor: Rene Kahn
Active, not recruiting --> Completed Initiation date: Jan 2011 --> May 2011
- olanzapine / Generic mfg., amisulpride / Generic mfg., clozapine / Generic mfg.
Enrollment open: OPTIMISE: Optimization of Treatment and Management of Schizophrenia in Europe (clinicaltrials.gov) - Jun 28, 2012
P4, N=350, Recruiting, Sponsor: Rene Kahn
Initiation date: Jan 2011 --> May 2011 Not yet recruiting --> Recruiting
- ||||||| paliperidone extended release / Generic mfg.
Trial completion: An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia (clinicaltrials.gov) - Jun 27, 2012
P3, N=228, Completed, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Recruiting Active, not recruiting --> Completed